Welcome to our dedicated page for Renatus Tactical Acquis SEC filings (Ticker: RTACW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Renatus Tactical Acquis's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Renatus Tactical Acquis's regulatory disclosures and financial reporting.
Renatus Tactical Acquisition Corp. I reported the resignation of director Matan Fattal, effective June 5, 2026. He also left the Audit, Compensation, and Nominating and Corporate Governance Committees, and his departure was stated not to arise from any dispute with the company or its Board.
The resignation leaves the Audit Committee with fewer than three members and the Board without a majority of independent directors, putting the company out of compliance with Nasdaq Listing Rules 5605(c)(2)(A) and 5605(b). Renatus has notified Nasdaq, plans to use the applicable cure periods, and is searching for a new independent director to restore compliance.
Renatus Tactical Acquisition Corp. I reported the resignation of director Matan Fattal, effective June 5, 2026. He also left the Audit, Compensation, and Nominating and Corporate Governance Committees, and his departure was stated not to arise from any dispute with the company or its Board.
The resignation leaves the Audit Committee with fewer than three members and the Board without a majority of independent directors, putting the company out of compliance with Nasdaq Listing Rules 5605(c)(2)(A) and 5605(b). Renatus has notified Nasdaq, plans to use the applicable cure periods, and is searching for a new independent director to restore compliance.
Renatus Tactical Acquisition Corp I reports net income of $1,808,560 for the quarter ended March 31, 2026, driven mainly by $2,091,474 of interest on its IPO trust assets, partly offset by $282,914 of formation and operating expenses.
Cash in the trust account reached $250,274,966, while cash outside the trust was only $10,977, leading management to highlight substantial doubt about the company’s ability to continue as a going concern without additional financing or a business combination.
The SPAC has 24,150,000 Class A ordinary shares subject to redemption and 7,011,288 Class B ordinary shares outstanding, has issued investor convertible notes totaling $330,000, and is still seeking a suitable target for its initial business combination.
Renatus Tactical Acquisition Corp I reports net income of $1,808,560 for the quarter ended March 31, 2026, driven mainly by $2,091,474 of interest on its IPO trust assets, partly offset by $282,914 of formation and operating expenses.
Cash in the trust account reached $250,274,966, while cash outside the trust was only $10,977, leading management to highlight substantial doubt about the company’s ability to continue as a going concern without additional financing or a business combination.
The SPAC has 24,150,000 Class A ordinary shares subject to redemption and 7,011,288 Class B ordinary shares outstanding, has issued investor convertible notes totaling $330,000, and is still seeking a suitable target for its initial business combination.